Europe has strengthened its push for technological sovereignty with the launch of the Euro Q Exa quantum computing system in Munich, marking a significant addition to the continent’s developing ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

Dianthus Therapeutics (NASDAQ:DNTH) executives used a Biotech Summit 2026 discussion to outline upcoming clinical catalysts ...

Carlos Ledó Orriach of Veganic and Dr. Willian Batista Silva of Rainbow Bio answer your toughest questions on biological ...

The study of immune inflammatory responses centers on the intricate molecular pathways that both initiate and modulate these processes. Inflammation is ...

Experience a garden in Pennsylvania so gorgeous and serene, it evokes the soft, vibrant beauty of a Claude Monet masterpiece.

The curriculum is structured around a comprehensive MSc Psychology syllabus that integrates classical psychological theories with applied practice. From diagnostic assessment to counselling ...

Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.

Performances in N.Y.C. Advertisement Supported by Thinking outside the canon, and finding the gritty and the beautiful, within it. By Joshua Barone and Corinna da Fonseca-Wollheim JOSHUA BARONE Few ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...